Scinopharm Taiwan Limited operates within the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Scinopharm Taiwan Limited with three other
companies in this sector in Taiwan:
Chunghwa Chemical Synthesis & Biotech Co Ltd
sales of 1.20 billion Taiwanese Dollars [US$41.15 million]
of which 53%
Savior Lifetec Corp
(1.53 billion Taiwanese Dollars [US$52.60 million]
of which 100%
was Drugs Development, Production and Sales), and
Sci Pharmtech Inc
(1.90 billion Taiwanese Dollars [US$65.33 million]
of which 100%
was Manufacture and Sale of Pharmaceutical).
During the year ended December of 2016, sales at
Scinopharm Taiwan Limited were 4.03 billion Taiwanese Dollars (US$138.38 million).
a very small
increase of 1.9%
versus 2015, when the company's sales were 3.96 billion Taiwanese Dollars.
Despite this increase, sales are still
below the level achieved in 2014, when Scinopharm Taiwan Limited
reported sales of 4.10 billion Taiwanese Dollars.
The sales level in 2016 was fairly close to the level five years ago: in 2011, Scinopharm Taiwan Limited had sales
of 3.95 billion Taiwanese Dollars.
Sales of Other saw an increase
that was more than double the company's growth rate: sales were up
145.1% in 2016, from
58.07 million Taiwanese Dollars to 142.31 million Taiwanese Dollars.
Not all segments of Scinopharm Taiwan Limited experienced an increase in sales in 2016:
sales of Taiwan Shenlong fell 0.2% to 3.89 billion Taiwanese Dollars.